Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 802 | -807 | 328 | 992 | 1,157 |
| Operating Income | -802 | 807 | -328 | -992 | -1,157 |
| Interest Expense | 156 | -1,042 | 0 | 1,339 | -250 |
| Other Income | -2,947 | -391 | 0 | -179 | 191 |
| Pre-tax Income | -3,904 | 1,458 | -328 | -2,509 | -716 |
| Net Income Continuous | -3,904 | 1,458 | -328 | -2,509 | -716 |
| Net Income | $-3,904 | $1,458 | $-328 | $-2,509 | $-716 |
| EPS Basic Total Ops | -6,820.91 | 707,464.80 | -692,584.80 | -14,355.39 | -4,197.48 |
| EPS Basic Continuous Ops | -6,819.38 | 704,052.00 | -688,666.40 | -14,411.70 | -4,633.67 |
| EPS Diluted Total Ops | -6,820.91 | 707,464.80 | -692,584.80 | -14,355.39 | -4,197.48 |
| EPS Diluted Continuous Ops | -6,819.38 | 704,052.00 | -688,666.40 | -14,411.70 | -4,633.67 |
| EBITDA(a) | $-776 | $833 | $-264 | $-1,002 | $-1,133 |